MicroGen Biotech uses Nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil.
MicroGen Biotech has raised €3.5M across 1 funding round from 1 investor, most recently a Series A round in Jul 2020. Based in Carlow, Ireland; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-05 | Series A |
| €3.5M |
| Fulcrum Global Capital |
| View deal → |
